SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $24,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,125,000 | $5,780,000 | 0.62% |
| RA Capital Management | 2,471,456 | $6,722,000 | 0.52% |
| DAFNA Capital Management LLC | 373,702 | $1,016,000 | 0.49% |
| BVF INC/IL | 1,684,636 | $4,582,000 | 0.46% |
| OIKOS HOLDINGS LLC | 182,395 | $496,000 | 0.39% |
| Eventide Asset Management | 2,265,455 | $6,162,000 | 0.29% |
| Telemetry Investments, L.L.C. | 175,000 | $476,000 | 0.18% |
| NEA Management Company, LLC | 1,298,274 | $3,531,000 | 0.16% |
| Rhenman & Partners Asset Management AB | 450,100 | $1,224,000 | 0.15% |
| Palo Alto Investors LP | 1,162,473 | $3,162,000 | 0.14% |